Ionis Pharmaceuticals, Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on IONS yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Novartis shares fell after the company updated its mid-term outlook. The headline gives no detail on the revised targets, and Ionis Pharmaceuticals is also named by the feed.
Biogen released new mid-stage data for diranersen, an early Alzheimer's asset developed with Ionis Pharmaceuticals. The headline gives no detail on the results, so their impact on either stock is unclear.
No SEC financials for IONS yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.